Stem cells may help identify new schizophrenia drugs

Human astrocytes were produced from iPSCs using 3D methods described in the paper. The astrocytes were then stained with antibodies against C4 (green; the target of the work), ALDH1L1 (red; a marker for astrocytes) and DAPI (blue – which looks purple in the image -- a nuclear marker).
Credit: Francesca Rapino, Harvard University, USA

Inflammation and overactivation of the immune system in the brain can cause loss of synapses and the death of neurons, leading to neurodegenerative and psychiatric diseases.

In Schizophrenia, increased levels of the immune protein C4 have been measured in patients’ brains and increasing C4 levels due to variations in copy number are associated with an increased risk for developing Schizophrenia. Therapies lowering C4 levels in the brain and reducing inflammation may benefit Schizophrenia patients but are currently not available.

Brain cells called astrocytes regulate the immune response and inflammatory environment in the brain by secreting immune proteins such as C4. Consequently, astrocytes are a primary target for C4-lowering therapies.

To identify effective drugs, Francesca Rapino, Lee Rubin, and colleagues from Harvard University, USA have developed an efficient method to make large numbers of C4-secreting human astrocytes from stem cells. In a paper recently published in Stem Cell Reports, the researchers followed-up with a screen of 464 drugs and identified a small group of about 20 that reduced C4 secretion from astrocytes.

These drugs were effective both in healthy astrocytes and in astrocytes made from Schizophrenia patients’ stem cells. This research opens up new avenues for studying inflammatory responses and their regulation in human astrocytes and serves as a platform to identify therapeutic drugs in large-scale screening approaches.

Journal: Stem Cell Reports
DOI: 10.1016/j.stemcr.2022.11.018
Article Title: Small molecule screen reveals pathways that regulate C4 secretion in stem-cell derived astrocytes
Article Publication Date: 22-Dec-2022

Media Contact

Kym Kilbourne
International Society for Stem Cell Research
kkilbourne@isscr.org
Office: 443-995-2102

www.isscr.org

Expert Contact

Lee Rubin
Harvard University
lee_rubin@harvard.edu

www.harvard.edu

Media Contact

Kym Kilbourne
International Society for Stem Cell Research

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Super-precise spectrometer enabled by latent information carried by photons

Two researchers at the University of Warsaw developed a quantum-inspired super-resolving spectrometer for short pulses of light. The device designed in the Quantum Optical Devices Lab at the Centre for…

New method for fingerprint analysis holds great promise

Overlapping and weak fingerprints pose challenges in criminal cases. A new study offers a solution and brings hope for using chemical residues in fingerprints for personal profiling. A groundbreaking study…

Neoself-antigens induce autoimmunity in lupus

Reactivation of Epstein–Barr virus infection increases the production of neoself-antigens, which induce an autoimmune response, in patients with lupus. Autoimmune diseases are widespread and notoriously difficult to treat. In part,…

Partners & Sponsors